health

Tighter Budgets Threaten HIV/AIDS Gains

Matthew O. Berger and Peter Boaz

WASHINGTON, Sep 28 2010 (IPS) – Although the world will miss the 2010 deadline for universal access to HIV treatment, some countries, notably in sub- Saharan Africa, have made real strides forward, three United Nations agencies reported Tuesday.
The goal was set in 2006, but, as the joint report lays out, only some countries will achieve universal access, defined as coverage of at least 80 percent of the population in need, by the end of this year.

As with many health goals, progress is marked by unevenness both between regions and between aspects of the treatment needed.

While prevention efforts to reach the most at-risk populations globally – sex workers, drug users and men who have sex with men – are still limited, for instance, the report points to steady progress in providing access to services meant to prevent mother-to-child transmission of HIV.

Over half of all pregnant women with HIV in low- and middle- income countries received antiretroviral treatment to prevent transmission to their children, said the report, by UNICEF, UNAIDS and the World Health Organisation.

Within that number, there are sharp disparities between countries. There are countries, especially in southern Africa, that have made really encouraging progress, and in fact four of them have reached the universal access targets, Jimmy Kolker, chief of HIV and AIDS at UNICEF, told IPS Tuesday.
Related IPS Articles

But, he said, the same is not true in places like Nigeria, home to almost a third of the women globally who should be but are not getting antiretrovirals to prevent trasmission to newborns.

Half of that global unmet need, in fact, is in just four countries – Nigeria, the Democratic Republic of Congo, India and Uganda.

The report is based on 2009 numbers, so the final word on progress toward the universal access goal will come next year. New goals for how best to proceed in response to HIV/AIDS globally also will be set next year.

Within that discussion, Kolker said that there is now a sense that the 2015 goal should be elimination of mother-to- child transimission – a slight change in emphasis from the access-to-care goals of 2006 to 2010. It would be measuring not input, which is giving drugs to the mother, but output, which is an AIDS-free kid, he explained.

One obstacle toward both new and existing goals is the stagnation and even decline in donor funding over the past several years, largely attributed to the financial crisis. This is highlighted in the report, which said that the sustainability of many HIV programmes is being paradoxically put at risk due to lack of financial commitments at the same time that there is more evidence than ever before that such programmes are having a positive and growing impact.

How much is needed to keep these programmes afloat? Ten billion dollars, Bernhard Schwartlander, director of evidence, strategy and results at UNAIDS, told IPS.

Next week, donor countries are expected to reaffirm their commitments to the Global Fund to Fight AIDS, Tuberculosis and Malaria at a meeting at the U.N. in New York.

But, going forward, the fight will take more than donor largesse, said Kolker.

Because of the financial situation globally and the fact that the money is unlikely to get larger, national governments [in developing countries] themselves need to pick up the slack, he said. The good news is that more of the AIDS expenditure proportionally is coming from national governments. Decisions in countries like Kenya, Botswana, South Africa, Namibia to pay for the antiretrovirals themselves is a huge step forward, and that needs to be encouraged.

We are not going to be able to reverse the epidemic unless national partners and especially national governments see this as a good investment of their own resources, he added.

That investment will also likely need to be used differently and put to better use. The problem is we defintely need more money, but we also recognise we need to be more efficient in the way we are doing business, said Schwartlander.

Part of that is integrating HIV work better with work in other, related health areas. Kolker mentioned how the Global Fund and the U.S. fund known as PEPFAR began as emergency responses, but as the worst of the HIV crisis is brought under control they will need to address related issues like those relating to maternal health.

Services will need to be integrated and not provided at different locations as unlinked services. The direction we are going in clearly is in integration of services, he said.

And progress against the worst of the crisis is being made.

Though there are still 33.4 million people living with HIV worldwide and 2.7 million diagnosed in 2008 alone, the number of people receiving antiretroviral therapy in low- and middle-income countries increased by 1.2 million in 2009, representing the largest single-year increase ever and bringing the number to 5.25 million, according to the Tuesday s report, entitled Towards Universal Access .

Still, two-thirds of the population in need remains without access to antiretroviral therapy, an estimated 60 percent of developing-world patients do not know their HIV status, and many prevention efforts continue to lag.

The report warns that national strategies must include special efforts to reach the poorest of the poor and those who are socially excluded and that efforts to reach Millennium Development Goal six – to halt and reverse the spread of HIV/AIDS and other diseases by 2015 – has spurred changes in many national health systems.

As Kolker explained, HIV treatment was originally introduced at central hospitals with specialised care, but the universal access principal meant that had to be brought to the lowest level of care. In the case of mother-to-child transmission that meant going into the maternity clinics, the antenatal clinics, the village health units and that has largely been done The effort to make this universally available has succeeded largely in almost every country.

But, he warns, access to facilities is not the same as actual prevention of a new infection.

 

Related Posts

Innov8: The Future of Healthcare Investing

Innov8 is a company that is revolutionizing the way people invest in healthcare. The company offers top-of-the-range health supplements that are exclusive to the company. These supplements are designed to improve the customer s health and well-being, and they can also help them to earn a significant income. 

How it works 

Innov8 works by providing people with the opportunity to become a distributor of their health supplements. As a distributor, one will be able to sell their products to their friends, family, and colleagues. They will also be able to build a network of distributors under them, and they will earn a commission on all of the products that they sell. 

The benefits of becoming a distributor 

There are many benefits to becoming a distr…

Fitness Psychology: 4 Strategies For Achieving Goals

Achieving is not just about lifting weights, running faster, or mastering complex yoga poses. While these physical achievements are significant, they are only one side of the coin. The other side, often less talked about but equally important, is the fitness psychological aspect. This involves harnessing the power of your mind to propel you toward your fitness goals.

Psychology of fitness

The mind plays a pivotal role in . It s the driving force that gets you out of bed for an early morning run, pushes you to complete that last set of squats, and helps you stay committed to your diet. Succumbing to laziness, procrastination, or discouragement is accessible without a solid mental foundation.

Understanding the psychological aspects of fitness is crucia…

The Role of Health Tech Consulting in Transforming Healthcare

In today s quickly changing healthcare environment, the role of has become increasingly vital. Healthcare organizations are constantly striving to enhance patient care, improve operational efficiency, and stay ahead in an ever-competitive market. This article delves into the significance of health tech consulting and how it is revolutionizing the healthcare industry.

Advancing Healthcare Through Technology

Health tech consulting, often referred to as healthcare technology consulting, plays a pivotal role in leveraging cutting-edge technology to advance healthcare services. This sector focuses on integrating innovative solutions and digital tools to streamline processes, enhance patient outcomes, and reduce costs.

Enhancing Patient Care

One of the pr…

The Future of Medical Note-Taking: Dictaphone Stethoscope Style

In the ever-evolving field of healthcare, advancements in technology continue to shape the way medical professionals operate. One such innovation that promises to revolutionize the way doctors and nurses take notes is the Stethoscope. This combination of traditional and cutting-edge technologies holds the potential to streamline patient care, improve accuracy, and enhance overall efficiency in healthcare settings.

The Evolution of Medical Note-Taking

Medical note-taking is an essential aspect of patient care. Accurate and comprehensive notes are crucial for tracking patient history, ensuring proper diagnosis, and providing optimal treatment. Traditionally, healthcare providers relied on handwritten notes, which could be time-consuming and prone to errors. How…

Unleashing the Smile Revolution: Unveiling the Advantages of Dental Care in Mexico

 

Introduction:

Are you tired of paying exorbitant prices for quality dental care? Look no further than , a burgeoning hub for dental tourism that offers a wealth of advantages compared to other countries. Nestled on the US-Mexico border, Tijuana shines as a prime destination, attracting patients seeking affordable excellence. Join us as we delve into the unparalleled advantages of receiving dental care in Mexico, revolutionizing the way you approach dental treatments.

1. Cost-Effective Excellence:

One of the paramount advantages of choosing Mexico for dental care is the significant cost savings compared to other countries. The skyrocketing costs of dental treatments have become a major concern for patients worldwide. However, Mexico offers a co…

Targeting Tumor Suppression Pathways IN LUNG CANCER: Genprex’s take on precision medicine

Lung cancer continues to be a stark reality in the global health conversation, relentlessly claiming lives and leaving a trail of despair. In the U.S. alone, over 238,000 new lung cancer cases are anticipated in 2023, with a slightly higher incidence in women than men. Even more alarming, nearly 48,000 non-smokers in the U.S. are expected to be diagnosed in 2023. These grim statistics underscore the dire need for innovative treatments. , a leading biopharmaceutical firm, is stepping up to this challenge, aiming to develop cutting-edge therapies targeting tumor suppression pathways​.

The Promise of Gene Therapy

Gene therapy holds great promise in revolutionizing the treatment of various diseases and conditions. With its ability to target specific genetic def…

Leave a Reply

Your email address will not be published. Required fields are marked *